GTCR

News

Ex-Sanofi generics company Zentiva is poised for a sale by current owner Advent International to US investment group GTCR, says a media report.

News

AstraZeneca has launched a cost-cutting programme that will aim to slash $1.5bn a year off its costs, with the savings reinvested in R&D.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.